Bartosz Hudzik: Top 10 Advances in Thrombosis and Antithrombotic Therapy in 2025
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared on LinkedIn:
“Top 10 Advances in Thrombosis and Antithrombotic Therapy (2025)
Clinical practice in cardiovascular medicine continues to evolve rapidly. This visual summary highlights key trials and registries shaping how we manage ACS, atrial fibrillation, and valve disease in 2025.
What stands out?
- Shorter and more targeted antiplatelet strategies after PCI
- Growing evidence supporting DOAC-based approaches in AF and select high-risk settings
- Re-thinking aspirin duration and intensity in ACS and post-CABG patients
- New data on valve thrombosis, bioprosthetic valves, and pregnancy outcomes with heart prostheses
- Persistent gaps where evidence is still urgently needed
Trials like TARGET-FIRST, NEO-MINDSET, TACSI, AQUATIC, COMBINE-AF, and PRESTIGE-AF are refining day-to-day decision-making, while registries such as ROPAC III remind us how much work remains in special populations.
As always, translating these findings into individualized patient care—balancing ischemic and bleeding risk—remains the real challenge.
Which of these studies do you think will most change practice in the next year?”
More posts featuring Bartosz Hudzik.
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’
-
Jun 29, 2026, 13:01Edward Lee Carter: Exploring Anticoagulation Paradox